Free Trial
OTCMKTS:CHGCY

Chugai Pharmaceutical (CHGCY) Stock Price, News & Analysis

Chugai Pharmaceutical logo
$23.27 -0.14 (-0.60%)
As of 07/11/2025 03:59 PM Eastern

About Chugai Pharmaceutical Stock (OTCMKTS:CHGCY)

Key Stats

Today's Range
$22.33
$23.50
50-Day Range
$23.19
$30.18
52-Week Range
$18.39
$31.26
Volume
1.58 million shs
Average Volume
166,851 shs
Market Capitalization
$76.58 billion
P/E Ratio
28.73
Dividend Yield
1.07%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Chugai Pharmaceutical Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
20th Percentile Overall Score

CHGCY MarketRank™: 

Chugai Pharmaceutical scored higher than 20% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Chugai Pharmaceutical.

  • Earnings Growth

    Earnings for Chugai Pharmaceutical are expected to grow by 5.41% in the coming year, from $0.74 to $0.78 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Chugai Pharmaceutical is 28.73, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 25.85.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Chugai Pharmaceutical is 28.73, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 28.26.

  • Price to Book Value per Share Ratio

    Chugai Pharmaceutical has a P/B Ratio of 6.11. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Chugai Pharmaceutical's valuation and earnings.
  • Percentage of Shares Shorted

    0.00% of the float of Chugai Pharmaceutical has been sold short.
  • Short Interest Ratio / Days to Cover

    Chugai Pharmaceutical has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Chugai Pharmaceutical has recently increased by 80.00%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Chugai Pharmaceutical pays a meaningful dividend of 1.10%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Chugai Pharmaceutical does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Chugai Pharmaceutical is 32.10%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, Chugai Pharmaceutical will have a dividend payout ratio of 33.33% next year. This indicates that Chugai Pharmaceutical will be able to sustain or increase its dividend.

  • Read more about Chugai Pharmaceutical's dividend.
  • Percentage of Shares Shorted

    0.00% of the float of Chugai Pharmaceutical has been sold short.
  • Short Interest Ratio / Days to Cover

    Chugai Pharmaceutical has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Chugai Pharmaceutical has recently increased by 80.00%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Chugai Pharmaceutical has a news sentiment score of 0.51. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.99 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Chugai Pharmaceutical this week, compared to 0 articles on an average week.
Receive CHGCY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Chugai Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter.

CHGCY Stock News Headlines

Chugai Pharmaceutical Co., Ltd. (4519.T)
Presidential Bombshell: $150T Resource to Be Released as soon as this Summer?
Something extraordinary is happening in Washington. For the first time in over a century, a sitting President could release a national treasure that's been tied up in red tape, for generations. I'm talking about a $150 trillion American asset that's scattered across all 50 states. While the mainstream media focuses on political theater, this story is quietly developing behind closed doors.
Jefferies Keeps Their Hold Rating on Chugai Pharmaceutical Co (CHGCF)
Bernstein Remains a Buy on Chugai Pharmaceutical Co (CHGCF)
See More Headlines

CHGCY Stock Analysis - Frequently Asked Questions

Chugai Pharmaceutical's stock was trading at $21.97 at the beginning of the year. Since then, CHGCY stock has increased by 5.9% and is now trading at $23.27.

Chugai Pharmaceutical Co., Ltd. Unsponsored ADR (OTCMKTS:CHGCY) released its earnings results on Thursday, April, 24th. The company reported $0.19 EPS for the quarter. The company had revenue of $1.89 billion for the quarter. Chugai Pharmaceutical had a net margin of 33.56% and a trailing twelve-month return on equity of 21.71%.

Shares of CHGCY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
4/24/2025
Today
7/12/2025
Next Earnings (Estimated)
7/24/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
N/A
Current Symbol
OTCMKTS:CHGCY
CIK
1453934
Fax
N/A
Employees
7,778
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
$0.81
Trailing P/E Ratio
28.73
Forward P/E Ratio
31.45
P/E Growth
N/A
Net Income
$2.56 billion
Net Margins
33.56%
Pretax Margin
46.39%
Return on Equity
21.71%
Return on Assets
18.98%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
7.28
Quick Ratio
6.16

Sales & Book Value

Annual Sales
$7.74 billion
Price / Sales
9.89
Cash Flow
$0.84 per share
Price / Cash Flow
27.64
Book Value
$3.81 per share
Price / Book
6.11

Miscellaneous

Outstanding Shares
3,291,030,000
Free Float
N/A
Market Cap
$76.58 billion
Optionable
Not Optionable
Beta
0.66
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (OTCMKTS:CHGCY) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners